SEC Form 4 · accession 0001127602-15-012652
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cox
Officer — EVP Pharmaceutical Oper & Tech
Period of report
Mar 25, 2015
Accepted (ET)
Mar 26, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 25, 2015 | M | 2,175 | $72.87 | A | 34,686 | D | |
| Common Stock | Mar 25, 2015 | M | 2,891 | $60.56 | A | 37,577 | D | |
| Common Stock | Mar 25, 2015 | S | 12,010 | $449.06 | D | 25,567 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $72.87 | Mar 25, 2015 | M | 2,175 | D | — | Nov 1, 2017 | Common Stock | 2,175 | 0 | D |
| Stock Option (Right to Buy)F3 | $60.56 | Mar 25, 2015 | M | 2,891 | D | — | Feb 12, 2018 | Common Stock | 2,891 | 2,892 | D |
Explanation of responses
- F1Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2The stock options vest in four (4) equal annual installments commencing one year after the grant date of 11/1/2007.
- F3The stock options vest in four (4) equal annual installments commencing one year after the grant date of 2/12/2008.